| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |